Tradjenta Tablet, Film Coated
Product Images NDC 50090-4383

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tradjenta (NDC 50090-4383). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904383)

Label Image (Lbl500904383)
Tradjenta 5 mg film-coated tablets label showing the active ingredient linagliptin. The label identifies 90 tablets per package, with storage instructions to keep between 68 to 77 degrees Fahrenheit. The product is distributed by A-S Medication Solutions in Libertyville, Illinois. NDC 50090-4383-0 is visible.*
FDA Label Image

Chemical Structure (Tradjenta 01)

Chemical Structure (Tradjenta 01)
Chemical structure of linagliptin, the active ingredient in Tradjenta 5 mg oral film-coated tablets by A-S Medication Solutions. The structure shows a complex molecular arrangement with multiple nitrogen atoms and functional groups characteristic of linagliptin.*
FDA Label Image

Figure 1 (Tradjenta 02)

Figure 1 (Tradjenta 02)
A Kaplan-Meier curve comparing the percentage of patients with events over time (up to 3.5 years) for placebo and linagliptin. The plot shows two lines: a solid line for placebo and a dotted line for linagliptin, with similar event rates over the study period. A table below the graph indicates the number of patients at risk at various time points for each group.*
FDA Label Image

Scan Here (Tradjenta 03)

Scan Here (Tradjenta 03)
A Kaplan-Meier curve chart comparing the percentage of patients with an event over approximately 7 years between Linagliptin and Glimepiride treatments. The x-axis represents the years, and the y-axis shows the percentage of patients with events. A table below indicates the number of patients at risk over time for both treatments.*
FDA Label Image

Tradjenta 04

Tradjenta 04
The image shows a medication bottle label for Tradjenta 5 mg film-coated tablets. It indicates the active ingredient linagliptin and is labeled for oral use. The product is by A-S Medication Solutions. The label includes a QR code, and features typical pharmaceutical label elements such as dosage and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.